These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11828780)
1. Preparing for the introduction of new technologies: who is going to pay for them? Marshall PR J Cardiovasc Manag; 2002; 13(1):14-20. PubMed ID: 11828780 [No Abstract] [Full Text] [Related]
2. Drug-eluting stents: the panacea for restenosis? Lim MC Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043 [No Abstract] [Full Text] [Related]
3. New research in vascular brachytherapy applications beyond coronary artery disease. Guerra P; Bonan R J Invasive Cardiol; 2003 Jan; 15 Suppl A():31A-32A. PubMed ID: 12668840 [No Abstract] [Full Text] [Related]
4. Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease. Dobesh PP; Stacy ZA; Ansara AJ; Enders JM Pharmacotherapy; 2004 Nov; 24(11):1554-77. PubMed ID: 15537561 [TBL] [Abstract][Full Text] [Related]
5. [Restenosis inside the stent: treatment and prevention]. Arablinskiĭ AV; Zakharova OV; Kononov AV Klin Med (Mosk); 2004; 82(9):10-3. PubMed ID: 15540414 [No Abstract] [Full Text] [Related]
7. [Drug-eluting stents and other anti-restenosis devices]. Moreno R Rev Esp Cardiol; 2005 Jul; 58(7):842-62. PubMed ID: 16022816 [TBL] [Abstract][Full Text] [Related]
8. The future of coronary artery radiation therapy--"the CART before the (unbridled) horse!". Point. Devlin PM Brachytherapy; 2003; 2(2):73-4. PubMed ID: 15062142 [No Abstract] [Full Text] [Related]
9. The future of CART in the era of drug eluting stents: "It's not over until it's over". Counterpoint. Tripuraneni P Brachytherapy; 2003; 2(2):74-6. PubMed ID: 15062143 [No Abstract] [Full Text] [Related]
10. Managing technological explosion in the medical management of coronary artery disease, Part II. DES economic modeling: budgeting strategies for drug-eluting stent technology. Chumer K; DeCerce J; Vaul J J Cardiovasc Manag; 2002; 13(4):16-20. PubMed ID: 12192774 [No Abstract] [Full Text] [Related]
11. Ensuring adequate payment for the use of new technology. Kaden RJ Healthc Financ Manage; 1998 Feb; 52(2):46-52. PubMed ID: 10176449 [TBL] [Abstract][Full Text] [Related]
13. The rush is on to acquire drug-eluting stents. Hosp Mater Manage; 2003 Jun; 28(6):2, 11. PubMed ID: 12825380 [No Abstract] [Full Text] [Related]
14. Vascular brachytherapy vs. drug-eluting stents for the treatment of in-stent restenosis: the jury's still out. Waksman R Catheter Cardiovasc Interv; 2004 Jul; 62(3):290-1. PubMed ID: 15224291 [No Abstract] [Full Text] [Related]
15. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease. Kohn J; Zeltinger J Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093 [TBL] [Abstract][Full Text] [Related]
16. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease. Degertekin M; Regar E; Tanabe K; Lee CH; Serruys PW Minerva Cardioangiol; 2002 Oct; 50(5):405-18. PubMed ID: 12384623 [TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stent: the emerging technique for the prevention of restenosis. Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626 [TBL] [Abstract][Full Text] [Related]
19. "At least but not at last" equivalent! Bonan R Catheter Cardiovasc Interv; 2004 Jul; 62(3):289. PubMed ID: 15224290 [No Abstract] [Full Text] [Related]
20. Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis. Saia F; Lemos PA; Hoye A; Sianos G; Arampatzis CA; de Feyter PJ; van der Giessen WJ; Smits PC; van Domburg RT; Serruys PW Catheter Cardiovasc Interv; 2004 Jul; 62(3):283-8. PubMed ID: 15224289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]